Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Ironwood Pharmaceuticals is a leading US-based biopharmaceutical company specializing in the development and commercialization of innovative therapies for gastrointestinal diseases. The company focuses on improving patient care through scientific excellence in addressing complex gastrointestinal conditions.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Ironwood Pharmaceuticals is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Ironwood Pharmaceuticals last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 0.31 USD.
Ironwood Pharmaceuticals has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.